What are the outcomes for adults who were born with HIV?
First-line ART failure common among hospitalised HIV-positive people in sub-Saharan Africa
More time with depression increases the risk of death for women with HIV
TAF only superior to TDF when used with a boosting agent
REALITY study shows which HIV-positive people with very low CD4 cell counts are at highest risk of dying soon after starting treatment
Integrase inhibitors do not raise risk of IRIS in severely immunocompromised people
Switching from abacavir to TAF improves platelet function
Failure of second-line ART is common in resource-limited countries, but modern third-line regimens work well
Powerful new PrEP and treatment drug should be effective as a small weekly pill
